Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human catechol-O-methyltransferase down-regulation by estradiol.

H Jiang1, T Xie, D B Ramsden

  • 1Division of Neurology, University Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, PR China.

Neuropharmacology
|October 24, 2003
PubMed
Summary

17beta-estradiol (E2) reduces catechol-O-methyltransferase (COMT) enzyme activity and protein levels in human cells. This estrogenic effect, mediated by the estrogen receptor, may explain sex-based differences in COMT activity and E2

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple sclerosis: assay of free immunoglobulin light chains.

Annals of clinical biochemistry·2016
Same author

Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn's disease: an observational study.

European journal of clinical nutrition·2016
Same author

The HhaI polymorphism in the CYP2D6 gene is not associated with Parkinson's disease in a Caucasian population.

European journal of neurology·2013
Same author

Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling.

Cell death & disease·2013
Same author

Detection of endocrine disruptors - from simple assays to whole genome scanning.

International journal of andrology·2012
Same author

Biomarkers of endocrine disruption: cluster analysis of effects of plasticisers on Phase 1 and Phase 2 metabolism of steroids.

International journal of andrology·2012

Area of Science:

  • Neuroscience
  • Endocrinology
  • Molecular Biology

Background:

  • Catechol-O-methyltransferase (COMT) is vital for dopamine and levodopa metabolism.
  • Previous research indicated 17beta-estradiol (E2) down-regulates COMT mRNA in MCF-7 cells.

Purpose of the Study:

  • Investigate E2's effect on COMT in a glial cell line (U138MG).
  • Determine if COMT protein and activity changes in MCF-7 cells mirror mRNA alterations.
  • Elucidate the mechanism of E2's action on COMT expression.

Main Methods:

  • Cell culture (MCF-7 and U138MG cells).
  • Quantitative analysis of COMT mRNA, protein, and enzyme activity.
  • Estrogen receptor antagonist (ICI 182780) treatment.
  • Electrophoretic mobility shift assay (EMSA) to assess estrogen receptor binding to COMT promoter regions.

Related Experiment Videos

Main Results:

  • E2 did not affect COMT mRNA in U138MG cells.
  • E2 significantly reduced COMT protein and activity in MCF-7 cells in a dose-dependent manner.
  • An estrogen receptor antagonist blocked E2's inhibitory effects.
  • EMSA confirmed estrogen receptor binding to COMT gene promoter regions.

Conclusions:

  • E2 decreases COMT activity by down-regulating gene and protein expression in MCF-7 cells via estrogen receptor interaction with promoter elements.
  • Findings suggest a potential explanation for lower COMT activity in women versus men.
  • Results may partially account for the therapeutic benefits of E2 in post-menopausal Parkinson's disease.